HB494 Alabama 2015 Session

Summary

Primary Sponsor

Ron Johnson

Republican

Session

Regular Session 2015

Title

Drug therapy management, joint committee of Board of Medical Examiners and Pharmacy Board, estab., adoption of rules by both boards, collaborative agreements between pharmacists and doctors, Secs. 34-23-200 to 34-23-212, inclusive, added

Summary

HB494 would create a formal system for collaborative drug therapy management between pharmacists and physicians, with rules and a joint committee to regulate it.

What This Bill Does

It authorizes collaborative drug therapy management between pharmacists and physicians under written protocols and requires rules to be adopted by the boards of Pharmacy and Medical Examiners. It creates a Joint Committee of three physicians and three pharmacists to develop rules and model protocols and to oversee collaboration practices. It allows pharmacists to order certain lab tests, administer drugs, and monitor or adjust medication regimens under those protocols, but it does not let pharmacists prescribe independently; hospitals may be exempt from the joint committee review if they have their own medical oversight, and there are provisions for oversight, discipline, appeals, and public health use during outbreaks.

Who It Affects

• Pharmacists: may participate in collaborative drug therapy management under written protocols and must operate under rules and joint oversight.
• Physicians: may collaborate with pharmacists under written protocols and be subject to oversight; a joint committee includes physician members and sets collaboration rules.

Key Provisions

• Creates the Collaborative Drug Therapy Management Act with a Joint Committee (3 physicians and 3 pharmacists) to develop and recommend rules and model protocols to the Board of Medical Examiners and the Board of Pharmacy.
• Authorizes licensed pharmacists to perform specific drug therapy management activities (order lab tests, administer drugs, monitor/adjust regimens) under written collaborative agreements with physicians, while prohibiting independent prescribing and establishing enforcement and dispute-resolution processes.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Health